The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 15, 2007

Filed:

May. 30, 2003
Applicants:

Catriona Helen M. Jamieson, Palo Alto, CA (US);

Laurie Elizabeth Ailles, Stanford, CA (US);

Tannishtha Reya, Mountain View, CA (US);

Irving L. Weissman, Redwood City, CA (US);

Inventors:

Catriona Helen M. Jamieson, Palo Alto, CA (US);

Laurie Elizabeth Ailles, Stanford, CA (US);

Tannishtha Reya, Mountain View, CA (US);

Irving L. Weissman, Redwood City, CA (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C12N 5/00 (2006.01); C12N 5/02 (2006.01); C12N 15/09 (2006.01); C12N 15/74 (2006.01); C12Q 1/68 (2006.01);
U.S. Cl.
CPC ...
Abstract

Methods and compositions are provided for the identification of stem cells and cancer stem cells. β-catenin is also identified as a target for the development of therapeutic moieties against hematopoietic tumors, i.e. leukemia and lymphoma cells, which may include screening assays directed at β-catenin, or members of the β-catenin signaling pathway. Cellular proliferation in hematopoietic cells can be altered by introducing stabilized β-catenin into a hematopoietic cell that is altered in its ability to undergo apoptosis but which is not fully transformed. The immortalized cells are useful in screening assays, and in the analysis of pathways by which hematopoietic cells undergo transformation.


Find Patent Forward Citations

Loading…